Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
November-2020 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2020 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Whole‑transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1‑MET fusion‑negative secondary glioblastoma multiforme

  • Authors:
    • Bao‑Shi Chen
    • Kuan-Yu Wang
    • Shu-Qing Yu
    • Chuan-Bao Zhang
    • Guan-Zhang Li
    • Zhi-Liang Wang
    • Zhao-Shi Bao
  • View Affiliations / Copyright

    Affiliations: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China, Department of Gamma Knife Center, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China, Department of Neurosurgery, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100050, P.R. China
    Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 187
    |
    Published online on: September 3, 2020
       https://doi.org/10.3892/ol.2020.12049
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Gliomas are the most common type of primary brain tumor in adults with a high mortality rate. Low‑grade gliomas progress to glioblastoma multiforme (GBM) in the majority of cases, forming secondary GBM (sGBM), followed by rapid fatal clinical outcomes. Protein tyrosine phosphatase receptor type Z1 (PTPRZ1)‑MET proto‑oncogene receptor tyrosine kinase (MET) (ZM) fusion has been identified as a biomarker for sGBM that is involved in glioma progression, but the mechanism of gliomagenesis and pathology of ZM‑negative sGBM has remained to be fully elucidated. A whole‑transcriptome signature is thus required to improve the outcome prediction for patients with sGBM without ZM fusion. In the present study, whole‑transcriptome sequencing on 42 sGBM samples with or without ZM fusion from the Chinese Glioma Genome Atlas database identified mRNAs with differential expression between patients with and without ZM fusion and the most significant survival‑associated genes were identified. A 6‑gene signature was identified as a novel prognostic model reflecting survival probability in patients with ZM‑negative sGBM. Clinical characteristics in patients with a high or low risk score value were analyzed with the Kaplan‑Meier method and a two‑sided log‑rank test. In addition, ZM‑negative sGBM patients with a high risk score exhibited an increase in immune cells, NF‑κB‑induced pathway activation and a decrease in endothelial cells compared with those with a low risk score. The present study demonstrated the potential use of a next‑generation sequencing‑based cancer gene signature in patients with ZM‑negative sGBM, indicating possible clinical therapeutic strategies for further treatment of such patients.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Wang Y and Jiang T: Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management. Cancer Lett. 331:139–146. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI

3 

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P and Ellison DW: The 2016 World Health organization classification of tumors of the central nervous system: A summary. Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI

5 

Mertens F, Johansson B, Fioretos T and Mitelman F: The emerging complexity of gene fusions in cancer. Nat Rev Cancer. 15:371–381. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, Castano A, Liu EM, Reichel J, Porrati P, Pellegatta S, et al: Transforming fusions of FGFR and TACC genes in human glioblastoma. Science. 337:1231–1235. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Bandopadhayay P, Ramkissoon LA, Jain P, Bergthold G, Wala J, Zeid R, Schumacher SE, Urbanski L, O'Rourke R, Gibson WJ, et al: MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nat Genet. 48:273–282. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Bao ZS, Chen HM, Yang MY, Zhang CB, Yu K, Ye WL, Hu BQ, Yan W, Zhang W, Akers J, et al: RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas. Genome Res. 24:1765–1773. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Zhang C, Cheng W, Ren X, Wang Z, Liu X, Li G, Han S, Jiang T and Wu A: Tumor Purity as an Underlying Key Factor in Glioma. Clin Cancer Res. 23:6279–6291. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Chai R, Zhang K, Wang K, Li G, Huang R, Zhao Z, Liu Y and Chen J: A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma. J Cancer Res Clin Oncol. 144:439–447. 2018. View Article : Google Scholar : PubMed/NCBI

11 

Wang Z, Zhang C, Liu X, Wang Z, Sun L, Li G, Liang J, Hu H, Liu Y, Zhang W and Jiang T: Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma. Oncoimmunology. 5:e11963102016. View Article : Google Scholar : PubMed/NCBI

12 

Wang K, Huang R, Li G, Zeng F, Zhao Z, Liu Y, Hu H and Jiang T: CKAP2 expression is associated with glioma tumor growth and acts as a prognostic factor in high-grade glioma. Oncol Rep. 40:2036–2046. 2018.PubMed/NCBI

13 

Pogorelyy MV, Fedorova AD, McLaren JE, Ladell K, Bagaev DV, Eliseev AV, Mikelov AI, Koneva AE, Zvyagin IV, Price DA, et al: Exploring the pre-immune landscape of antigen-specific T cells. Genome Med. 10:682018. View Article : Google Scholar : PubMed/NCBI

14 

Tirosh I, Izar B, Prakadan SM, Wadsworth MH II, Treacy D, Trombetta JJ, Rotem A, Rodman C, Lian C, Murphy G, et al: Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 352:189–196. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Deloukas P, Matthews LH, Ashurst J, Burton J, Gilbert JG, Jones M, Stavrides G, Almeida JP, Babbage AK, Bagguley CL, et al: The DNA sequence and comparative analysis of human chromosome 20. Nature. 414:865–871. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Ambele MA, Dessels C, Durandt C and Pepper MS: Genome-wide analysis of gene expression during adipogenesis in human adipose-derived stromal cells reveals novel patterns of gene expression during adipocyte differentiation. Stem Cell Res. 16:725–734. 2016. View Article : Google Scholar : PubMed/NCBI

17 

van Ree JH, Nam HJ, Jeganathan KB, Kanakkanthara A and van Deursen JM: Pten regulates spindle pole movement through Dlg1-mediated recruitment of Eg5 to centrosomes. Nat Cell Biol. 18:814–821. 2016. View Article : Google Scholar : PubMed/NCBI

18 

Feizabadi MS, Jun Y and Reddy JN: Distinctions between dynamic characteristics of the single EG5 motor protein along neural vs. Cancerous microtubules. Biochem Biophys Res Commun. 478:1630–1633. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Lu M, Zhu H, Wang X, Zhang D, Xiong L, Xu L and You Y: The prognostic role of Eg5 expression in laryngeal squamous cell carcinoma. Pathology. 48:214–218. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Yin Y, Sun H, Xu J, Xiao F, Wang H, Yang Y, Ren H, Wu CT, Gao C and Wang L: Kinesin spindle protein inhibitor SB743921 induces mitotic arrest and apoptosis and overcomes imatinib resistance of chronic myeloid leukemia cells. Leuk Lymphoma. 56:1813–1820. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Wissing MD, De Morree ES, Dezentje VO, Buijs JT, De Krijger RR, Smit VT, Van Weerden WM, Gelderblom H and van der Pluijm G: Nuclear Eg5 (kinesin spindle protein) expression predicts docetaxel response and prostate cancer aggressiveness. Oncotarget. 5:7357–7367. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Martens-de Kemp SR, Nagel R, Stigter-van Walsum M, van der Meulen IH, van Beusechem VW, Braakhuis BJ and Brakenhoff RH: Functional genetic screens identify genes essential for tumor cell survival in head and neck and lung cancer. Clin Cancer Res. 19:1994–2003. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Imai T, Oue N, Sentani K, Sakamoto N, Uraoka N, Egi H, Hinoi T, Ohdan H, Yoshida K and Yasui W: KIF11 Is Required for Spheroid Formation by Oesophageal and Colorectal Cancer Cells. Anticancer Res. 37:47–55. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Liu L, Liu X, Mare M, Dumont AS, Zhang H, Yan D and Xiong Z: Overexpression of Eg5 correlates with high grade astrocytic neoplasm. J Neurooncol. 126:77–80. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Venere M, Horbinski C, Crish JF, Jin X, Vasanji A, Major J, Burrows AC, Chang C, Prokop J, Wu Q, et al: The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma. Sci Transl Med. 7:304ra1432015. View Article : Google Scholar : PubMed/NCBI

26 

Katoh M and Katoh M: Identification and characterization of human FHDC1, mouse Fhdc1 and zebrafish fhdc1 genes in silico. Int J Mol Med. 13:929–934. 2004.PubMed/NCBI

27 

Copeland SJ, Thurston SF and Copeland JW: Actin- and microtubule-dependent regulation of Golgi morphology by FHDC1. Mol Biol Cell. 27:260–276. 2016. View Article : Google Scholar : PubMed/NCBI

28 

Wang Z, Chen S, Zhang L, Lu G, Zhou C, Wang DW, Wang L, Badengmu B, Zhai Z and Qin L: Association between variation in the genes DDAH1 and DDAH2 and hypertension among Uygur, Kazakh and Han ethnic groups in China. Sao Paulo Med J. 134:205–210. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Yuan Q, Hu CP, Gong ZC, Bai YP, Liu SY, Li YJ and Jiang JL: Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: Role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine. Biochem Biophys Res Commun. 458:869–876. 2015. View Article : Google Scholar : PubMed/NCBI

30 

Shiozawa T, Iyama S, Toshima S, Sakata A, Usui S, Minami Y, Sato Y, Hizawa N and Noguchi M: Dimethylarginine dimethylaminohydrolase 2 promotes tumor angiogenesis in lung adenocarcinoma. Virchows Arch. 468:179–190. 2016. View Article : Google Scholar : PubMed/NCBI

31 

Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H, et al: Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes. Genome Res. 16:55–65. 2006. View Article : Google Scholar : PubMed/NCBI

32 

Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 36:40–45. 2004. View Article : Google Scholar : PubMed/NCBI

33 

Rose JE, Behm FM, Drgon T, Johnson C and Uhl GR: Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Mol Med. 16:247–253. 2010. View Article : Google Scholar : PubMed/NCBI

34 

Sharma S, Watzinger P, Kotter P and Entian KD: Identification of a novel methyltransferase, Bmt2, responsible for the N-1-methyl-adenosine base modification of 25S rRNA in Saccharomyces cerevisiae. Nucleic Acids Res. 41:5428–5443. 2013. View Article : Google Scholar : PubMed/NCBI

35 

Racle J, de Jonge K, Baumgaertner P, Speiser DE and Gfeller D: Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife. 6:e264762017. View Article : Google Scholar : PubMed/NCBI

36 

Pasquale EB: Eph receptors and ephrins in cancer: Bidirectional signalling and beyond. Nat Rev Cancer. 10:165–180. 2010. View Article : Google Scholar : PubMed/NCBI

37 

Ahmed Z and Bicknell R: Angiogenic signalling pathways. Methods Mol Biol. 467:3–24. 2009. View Article : Google Scholar : PubMed/NCBI

38 

Dejana E, Orsenigo F, Molendini C, Baluk P and McDonald DM: Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res. 335:17–25. 2009. View Article : Google Scholar : PubMed/NCBI

39 

Tammela T and Alitalo K: Lymphangiogenesis: Molecular mechanisms and future promise. Cell. 140:460–476. 2010. View Article : Google Scholar : PubMed/NCBI

40 

Coffelt SB, Lewis CE, Naldini L, Brown JM, Ferrara N and De Palma M: Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. Am J Pathol. 176:1564–1576. 2010. View Article : Google Scholar : PubMed/NCBI

41 

Qian BZ and Pollard JW: Macrophage diversity enhances tumor progression and metastasis. Cell. 141:39–51. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen BS, Wang K, Yu S, Zhang C, Li G, Wang Z and Bao Z: Whole‑transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1‑MET fusion‑negative secondary glioblastoma multiforme. Oncol Lett 20: 187, 2020.
APA
Chen, B., Wang, K., Yu, S., Zhang, C., Li, G., Wang, Z., & Bao, Z. (2020). Whole‑transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1‑MET fusion‑negative secondary glioblastoma multiforme. Oncology Letters, 20, 187. https://doi.org/10.3892/ol.2020.12049
MLA
Chen, B., Wang, K., Yu, S., Zhang, C., Li, G., Wang, Z., Bao, Z."Whole‑transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1‑MET fusion‑negative secondary glioblastoma multiforme". Oncology Letters 20.5 (2020): 187.
Chicago
Chen, B., Wang, K., Yu, S., Zhang, C., Li, G., Wang, Z., Bao, Z."Whole‑transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1‑MET fusion‑negative secondary glioblastoma multiforme". Oncology Letters 20, no. 5 (2020): 187. https://doi.org/10.3892/ol.2020.12049
Copy and paste a formatted citation
x
Spandidos Publications style
Chen BS, Wang K, Yu S, Zhang C, Li G, Wang Z and Bao Z: Whole‑transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1‑MET fusion‑negative secondary glioblastoma multiforme. Oncol Lett 20: 187, 2020.
APA
Chen, B., Wang, K., Yu, S., Zhang, C., Li, G., Wang, Z., & Bao, Z. (2020). Whole‑transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1‑MET fusion‑negative secondary glioblastoma multiforme. Oncology Letters, 20, 187. https://doi.org/10.3892/ol.2020.12049
MLA
Chen, B., Wang, K., Yu, S., Zhang, C., Li, G., Wang, Z., Bao, Z."Whole‑transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1‑MET fusion‑negative secondary glioblastoma multiforme". Oncology Letters 20.5 (2020): 187.
Chicago
Chen, B., Wang, K., Yu, S., Zhang, C., Li, G., Wang, Z., Bao, Z."Whole‑transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1‑MET fusion‑negative secondary glioblastoma multiforme". Oncology Letters 20, no. 5 (2020): 187. https://doi.org/10.3892/ol.2020.12049
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team